Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial
Authors
Amit Oza,
Adrian CookSokbom Kang,
Andrew Embleton-Thirsk,
Jonathan Ledermann,
Éric Pujade-Lauraine,
Gunnar Kristensen,
Mark Sculpher,
Philip Beale,
Andrés Cervantes,
Tjoung‐Won Park‐Simon,
Gordon Rustin,
Florence Joly,
Mansoor Mirza,
Marie Plante,
Michael Quinn,
Andrés Poveda,
Gordon Jayson,
Dan Stark,
Ann Swart,
Laura Farrelly,
Richard Kaplan,
Mahesh Parmar,
Timothy Perren +22 authors
,
Andrès Cervantes Tip Tip